U.S. Wireless Telecom Stock News

Earlier this year, CSX announced a US$670 million agreement with Wabtec to upgrade its locomotive fleet with modern Evolution Series units, while partner TransloadX moved to revive two largely dormant Maine branch lines leased from CSX to support regional industrial rail activity. Together, these steps point to CSX pairing long-term efficiency upgrades in its core network with efforts to reactivate underused rail corridors through third-party investment. Next, we’ll examine how CSX’s US$670...

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...

If you are asking whether Target is priced fairly today, the starting point is understanding how the current share price lines up with different measures of value. The stock closed at US$119.84, with returns of 5.8% over 7 days, 2.9% over 30 days, 19.2% year to date, 20.9% over 1 year, and declines of 19.4% over 3 years and 31.0% over 5 years. Taken together, this gives you a mixed picture of both recent momentum and longer term risk. These moves sit against a backdrop where investors have...

Recent performance and what it might mean for TETRA Technologies (TTI) TETRA Technologies (TTI) has seen mixed share performance recently, with a 2.6% gain over the past day and 8.3% over the past week, compared with a decline of 22.6% over the past month and a 7.7% decline over the past three months. See our latest analysis for TETRA Technologies. Looking past the latest bounce, the 30 day share price return of negative 22.6% and year to date share price return of negative 11.95% sit against...

First Horizon (FHN) has drawn fresh attention after recent share moves, with the stock closing at US$22.13. For investors, that price invites a closer look at the bank’s fundamentals and current valuation. See our latest analysis for First Horizon. Over the past year, First Horizon’s 18.37% total shareholder return contrasts with a weaker recent patch, including a 30 day share price return of 9.64% decline. This suggests momentum has cooled even as longer term holders remain ahead. If First...

Event driven snapshot of Madrigal Pharmaceuticals Madrigal Pharmaceuticals (MDGL) has drawn investor attention after recent share price moves, including a 1 day return of about 2% and a 16% gain over the past week, against mixed month and past 3 months performance. See our latest analysis for Madrigal Pharmaceuticals. The recent 15.8% 7 day share price return contrasts with a weaker year to date share price performance and a much stronger 1 year total shareholder return of 55.8%. This...

Concentrix recently reported its first-quarter 2026 results, issued second-quarter and full-year guidance, confirmed a US$0.36 quarterly dividend for May 5, 2026, completed a large share repurchase program, and added Chih-Kai Cheng and Bilge Ogut to its board at the March 26 AGM. The combination of revenue growth alongside weaker earnings, expanding AI-focused offerings, ongoing capital returns, and refreshed board oversight highlights a business in the middle of a significant transformation...

Eli Lilly (NYSE:LLY) secured a partial legal win in its case against Fella Health over alleged misleading marketing of compounded tirzepatide. The court allowed core claims around consumer confusion and false advertising to continue, while rejecting other elements of Lilly’s complaint. Separately, four year data from the ADlong Phase 3b extension study showed durable skin clearance and itch relief with EBGLYSS (lebrikizumab-lbkz) in atopic dermatitis. Both updates affect Lilly’s positioning...

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...

Wondering if Northwest Natural Holding at US$52.83 is priced attractively or already reflects most of its potential? This article walks through the numbers so you can judge the valuation for yourself. The stock has returned 2.7% over the last 7 days, 5.7% over 30 days, 13.0% year to date and 29.6% over 1 year, with 3-year and 5-year returns of 27.9% and 23.9% respectively. These returns naturally raise questions about what is now baked into the price. Recent coverage has focused on how gas...

Get Joy, a functional gut-healthy dog nutrition company, has already rolled out its Freeze Dried Raw Chicken and Beef Meals into more than 360 Sprouts Farmers Market stores nationwide, following its nationwide launch that began on April 6. This expansion broadens Sprouts’ better-for-you pet assortment, aligning its pet aisles with wellness trends that increasingly mirror how customers shop for their own nutrition. Next, we’ll explore how adding Get Joy’s gut-focused dog meals could influence...

American Bitcoin Corp. has highlighted Hut 8 (NasdaqGS:HUT) as a key infrastructure partner. The company described Hut 8 as a "Bitcoin accumulation machine," underscoring its role in large scale mining operations. This recognition focuses on Hut 8's infrastructure that supports efficient Bitcoin mining and long term accumulation plans. For you as an investor, this puts fresh attention on what Hut 8 actually does in the Bitcoin mining value chain. Rather than only operating its own mining...

Peoples (OTCPK:PPLL) has just wrapped up FY 2025 with fourth quarter revenue of US$6.5 million and basic EPS of US$1.37, alongside trailing 12 month EPS of US$5.59 supported by net income of US$10.11 million on revenue of US$25.7 million. Over recent quarters, revenue has moved from US$5.4 million in Q4 2024 to US$7.1 million in Q3 2025 before landing at US$6.5 million in Q4 2025, with quarterly EPS ranging from US$1.06 in Q4 2024 to a peak of US$1.74 in Q3 2025. With trailing net profit...

Earlier this week, HP Inc. unveiled a broad slate of AI-powered PCs, security innovations, printers, and workflow tools aimed at reducing workplace friction and strengthening device protection across its commercial and consumer ecosystems. A distinctive element is HP IQ and its NearSense connectivity layer, which use on-device AI and proximity awareness to turn PCs, printers, and conferencing gear into a more cohesive, context-aware workplace platform. Next, we’ll examine how HP’s push into...

GitLab (GTLB) has drawn fresh attention after releasing GitLab 18.10, a product update centered on agentic AI features that could shape how investors think about its role in DevSecOps platforms. See our latest analysis for GitLab. Despite the AI-focused product launch and recent conference appearance, GitLab’s share price return has weakened, with a 30 day share price return of 21.64% and a year to date share price return of 43.75% at a last close of US$20.35. At the same time, the 1 year...

In recent days, analysts have highlighted Tyler Technologies ahead of its June 9 investor day and upcoming fiscal first-quarter 2026 earnings release, focusing on management’s intention to reiterate its 2030 revenue targets and discuss margins and AI’s longer-term role. An interesting thread for investors is how early-stage AI adoption and healthy software-as-a-service bookings expectations are shaping sentiment around Tyler’s long-term financial framework, even as meaningful AI-driven...

BlackSky Technology (BKSY) recently secured a seven-figure Assured extension contract with an international customer, highlighting continued use of its Gen-3 satellite imagery, AI-enabled analytics, and dual-generation tip-and-cue architecture. See our latest analysis for BlackSky Technology. The new contract arrives after a sharp 17.24% 1 day share price decline and a 10.73% 7 day share price return. However, the 30 day and 90 day share price returns of 15.35% and 20.61%, together with a 1...

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...

Hilton Worldwide Holdings (HLT) has drawn fresh investor attention after reporting a quarter where revenue came in 3.3% above analyst expectations and EBITDA guidance for the next quarter also exceeded forecasts. Even with these earnings and guidance beats highlighting Hilton’s position within the consumer discretionary travel and vacation providers sector, the stock has moved lower since the release. This has raised questions about how the market is reading the update. See our latest...

Kodiak Sciences recently reported positive topline results from its GLOW2 Phase 3 superiority study of Zenkuda in diabetic retinopathy, where the drug significantly outperformed sham across primary and key secondary endpoints while maintaining a favorable safety profile. A particularly important insight is that Zenkuda’s efficacy appeared consistent regardless of patients’ use of GLP-1 receptor agonists, supporting its potential relevance in a real-world diabetic population and strengthening...

If you are wondering whether Colgate-Palmolive at around US$84.29 is offering fair value or hiding a discount, this breakdown is designed to help you frame that question clearly. The share price has slipped around 1.0% over the last week and 12.8% over the last month, even though the year to date return is 8.5% and the 1 year return sits at 7.0% in decline, with 3 year and 5 year returns of 20.4% and 20.8% respectively. Recent attention on Colgate-Palmolive has centered on how the stock fits...

Recent performance snapshot Diversified Energy (DEC) has attracted fresh attention after a strong recent share price move, with the stock showing double digit gains over the past week, month and past 3 months. See our latest analysis for Diversified Energy. The recent surge in DEC's share price, with a 39.05% 1 month share price return and 22.70% year to date share price return, sits against a 44.68% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This...

Earlier this week, Hartford Insurance Group reported a very strong quarter, with revenue rising 6.7% year on year and results significantly ahead of analyst expectations compared with peers. What stands out is that Hartford delivered the biggest analyst estimate beat among its sector group, underscoring how its recent performance contrasts with many competitors. Now we’ll explore how this strong revenue growth and earnings beat may influence Hartford’s existing investment narrative and key...